Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Switching from Other SGLT2 Inhibitors to Tofogliflozin on Nocturnal Urination Frequency in Type 2 Diabetes Mellitus (SOS Study)
jRCT1051250226Recruiting
- Sponsor
- Nara Medical University
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tofogliflozin in type 2 diabetes mellitus (T2DM), sponsored by Nara Medical University. Started Feb 2026; status: recruiting.
02
Drugs
tofogliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT1051250226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051250226.